Concepedia

Publication | Closed Access

Efficacy of rituximab in refractory neuromyelitis optica

DOI

65

Citations

10

References

2015

Year

Nicolas Collongues, David Brassat, Élisabeth Maillart, Pierre Labauge, Clarisse Carra‐Dallière, T. Moreau, Bertrand Bourre, C Papeix, Bruno Brochet, Bertrand Audoin,
Multiple Sclerosis Journal

Abstract

RTX is an effective and well-tolerated treatment in RNMO. BMI could be a predictive factor for efficacy.

References

YearCitations

Page 1